APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Inhalable Drug Delivery Devices

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Inhalable Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17442562024 July 2026191 pages

Choose your research edition.

Industry ResearchInhalable Drug Delivery Devices Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalable Drug Delivery Devices Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Inhalable Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalable Drug Delivery Devices Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalable Drug Delivery Devices Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Inhalable Drug Delivery Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Inhalable Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhalable Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalable Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Inhalable Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inhalable Drug Delivery Devices include Acorda Therapeutics Inc, Baxter International Inc, Bellerophon Therapeutics Inc, Canigma A.L LTD, Edixomed Ltd, IDTx Systems, Inc., Impel NeuroPharma Inc, Kanabo Research Ltd and Mallinckrodt Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhalable Drug Delivery Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhalable Drug Delivery Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhalable Drug Delivery Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhalable Drug Delivery Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhalable Drug Delivery Devices Segment by Company

Acorda Therapeutics Inc

Baxter International Inc

Bellerophon Therapeutics Inc

Canigma A.L LTD

Edixomed Ltd

IDTx Systems, Inc.

Impel NeuroPharma Inc

Kanabo Research Ltd

Mallinckrodt Plc

Medical Developments International Ltd

Medspray BV

NeuroproteXeon Inc

Next Safety, Inc.

Nobilis Therapeutics Inc

Sandoz International GmbH

Vero biotech

Zambon

Inhalable Drug Delivery Devices Segment by Type

Nebulizers

Pressurized Metered Dose Inhalers (PMDIs)

Dry Powder Inhalers (DPIs)

Others

Inhalable Drug Delivery Devices Segment by Application

Hospital

Clinic

Others

Inhalable Drug Delivery Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalable Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalable Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalable Drug Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhalable Drug Delivery Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inhalable Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Inhalable Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Inhalable Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Inhalable Drug Delivery Devices Industry Trends Table 2. Inhalable Drug Delivery Devices Industry Drivers Table 3. Inhalable Drug Delivery Devices Industry Opportunities and Challenges Table 4. Inhalable Drug Delivery Devices Industry Restraints Table 5. Global Inhalable Drug Delivery Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Inhalable Drug Delivery Devices Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Inhalable Drug Delivery Devices Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Inhalable Drug Delivery Devices Sales Market Share by Manufacturers Table 9. Global Inhalable Drug Delivery Devices Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Inhalable Drug Delivery Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Inhalable Drug Delivery Devices Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Inhalable Drug Delivery Devices Manufacturers, Product Type & Application Table 13. Global Inhalable Drug Delivery Devices Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhalable Drug Delivery Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Nebulizers Table 17. Major Manufacturers of Pressurized Metered Dose Inhalers (PMDIs) Table 18. Major Manufacturers of Dry Powder Inhalers (DPIs) Table 19. Major Manufacturers of Others Table 20. Global Inhalable Drug Delivery Devices Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Inhalable Drug Delivery Devices Sales by Type (2021-2026) & (k units) Table 22. Global Inhalable Drug Delivery Devices Sales by Type (2027-2032) & (k units) Table 23. Global Inhalable Drug Delivery Devices Sales Market Share by Type (2021-2026) Table 24. Global Inhalable Drug Delivery Devices Sales Market Share by Type (2027-2032) Table 25. Global Inhalable Drug Delivery Devices Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Inhalable Drug Delivery Devices Revenue by Type (2021-2026) & (k units) Table 27. Global Inhalable Drug Delivery Devices Revenue by Type (2027-2032) & (k units) Table 28. Global Inhalable Drug Delivery Devices Revenue Market Share by Type (2021-2026) Table 29. Global Inhalable Drug Delivery Devices Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Others Table 33. Global Inhalable Drug Delivery Devices Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Inhalable Drug Delivery Devices Sales by Application (2021-2026) & (k units) Table 35. Global Inhalable Drug Delivery Devices Sales by Application (2027-2032) & (k units) Table 36. Global Inhalable Drug Delivery Devices Sales Market Share by Application (2021-2026) Table 37. Global Inhalable Drug Delivery Devices Sales Market Share by Application (2027-2032) Table 38. Global Inhalable Drug Delivery Devices Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Inhalable Drug Delivery Devices Revenue by Application (2021-2026) & (k units) Table 40. Global Inhalable Drug Delivery Devices Revenue by Application (2027-2032) & (k units) Table 41. Global Inhalable Drug Delivery Devices Revenue Market Share by Application (2021-2026) Table 42. Global Inhalable Drug Delivery Devices Revenue Market Share by Application (2027-2032) Table 43. Global Inhalable Drug Delivery Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Inhalable Drug Delivery Devices Sales by Region (2021-2026) & (k units) Table 45. Global Inhalable Drug Delivery Devices Sales Market Share by Region (2021-2026) Table 46. Global Inhalable Drug Delivery Devices Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Inhalable Drug Delivery Devices Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Inhalable Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Inhalable Drug Delivery Devices Sales by Country (2021-2026) & (k units) Table 50. North America Inhalable Drug Delivery Devices Sales by Country (2027-2032) & (k units) Table 51. Europe Inhalable Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Inhalable Drug Delivery Devices Sales by Country (2021-2026) & (k units) Table 53. Europe Inhalable Drug Delivery Devices Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Inhalable Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Inhalable Drug Delivery Devices Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Inhalable Drug Delivery Devices Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Inhalable Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Inhalable Drug Delivery Devices Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Inhalable Drug Delivery Devices Sales by Country (2027-2032) & (k units) Table 60. Global Inhalable Drug Delivery Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Inhalable Drug Delivery Devices Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Inhalable Drug Delivery Devices Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Inhalable Drug Delivery Devices Revenue Market Share by Region (2021-2026) Table 64. Global Inhalable Drug Delivery Devices Revenue Market Share by Region (2027-2032) Table 65. Acorda Therapeutics Inc Company Information Table 66. Acorda Therapeutics Inc Business Overview Table 67. Acorda Therapeutics Inc Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Acorda Therapeutics Inc Inhalable Drug Delivery Devices Product Portfolio Table 69. Acorda Therapeutics Inc Recent Development Table 70. Baxter International Inc Company Information Table 71. Baxter International Inc Business Overview Table 72. Baxter International Inc Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Baxter International Inc Inhalable Drug Delivery Devices Product Portfolio Table 74. Baxter International Inc Recent Development Table 75. Bellerophon Therapeutics Inc Company Information Table 76. Bellerophon Therapeutics Inc Business Overview Table 77. Bellerophon Therapeutics Inc Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Bellerophon Therapeutics Inc Inhalable Drug Delivery Devices Product Portfolio Table 79. Bellerophon Therapeutics Inc Recent Development Table 80. Canigma A.L LTD Company Information Table 81. Canigma A.L LTD Business Overview Table 82. Canigma A.L LTD Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Canigma A.L LTD Inhalable Drug Delivery Devices Product Portfolio Table 84. Canigma A.L LTD Recent Development Table 85. Edixomed Ltd Company Information Table 86. Edixomed Ltd Business Overview Table 87. Edixomed Ltd Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Edixomed Ltd Inhalable Drug Delivery Devices Product Portfolio Table 89. Edixomed Ltd Recent Development Table 90. IDTx Systems, Inc. Company Information Table 91. IDTx Systems, Inc. Business Overview Table 92. IDTx Systems, Inc. Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. IDTx Systems, Inc. Inhalable Drug Delivery Devices Product Portfolio Table 94. IDTx Systems, Inc. Recent Development Table 95. Impel NeuroPharma Inc Company Information Table 96. Impel NeuroPharma Inc Business Overview Table 97. Impel NeuroPharma Inc Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Impel NeuroPharma Inc Inhalable Drug Delivery Devices Product Portfolio Table 99. Impel NeuroPharma Inc Recent Development Table 100. Kanabo Research Ltd Company Information Table 101. Kanabo Research Ltd Business Overview Table 102. Kanabo Research Ltd Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Kanabo Research Ltd Inhalable Drug Delivery Devices Product Portfolio Table 104. Kanabo Research Ltd Recent Development Table 105. Mallinckrodt Plc Company Information Table 106. Mallinckrodt Plc Business Overview Table 107. Mallinckrodt Plc Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Mallinckrodt Plc Inhalable Drug Delivery Devices Product Portfolio Table 109. Mallinckrodt Plc Recent Development Table 110. Medical Developments International Ltd Company Information Table 111. Medical Developments International Ltd Business Overview Table 112. Medical Developments International Ltd Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Medical Developments International Ltd Inhalable Drug Delivery Devices Product Portfolio Table 114. Medical Developments International Ltd Recent Development Table 115. Medspray BV Company Information Table 116. Medspray BV Business Overview Table 117. Medspray BV Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Medspray BV Inhalable Drug Delivery Devices Product Portfolio Table 119. Medspray BV Recent Development Table 120. NeuroproteXeon Inc Company Information Table 121. NeuroproteXeon Inc Business Overview Table 122. NeuroproteXeon Inc Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. NeuroproteXeon Inc Inhalable Drug Delivery Devices Product Portfolio Table 124. NeuroproteXeon Inc Recent Development Table 125. Next Safety, Inc. Company Information Table 126. Next Safety, Inc. Business Overview Table 127. Next Safety, Inc. Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Next Safety, Inc. Inhalable Drug Delivery Devices Product Portfolio Table 129. Next Safety, Inc. Recent Development Table 130. Nobilis Therapeutics Inc Company Information Table 131. Nobilis Therapeutics Inc Business Overview Table 132. Nobilis Therapeutics Inc Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Nobilis Therapeutics Inc Inhalable Drug Delivery Devices Product Portfolio Table 134. Nobilis Therapeutics Inc Recent Development Table 135. Sandoz International GmbH Company Information Table 136. Sandoz International GmbH Business Overview Table 137. Sandoz International GmbH Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Sandoz International GmbH Inhalable Drug Delivery Devices Product Portfolio Table 139. Sandoz International GmbH Recent Development Table 140. Vero biotech Company Information Table 141. Vero biotech Business Overview Table 142. Vero biotech Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Vero biotech Inhalable Drug Delivery Devices Product Portfolio Table 144. Vero biotech Recent Development Table 145. Zambon Company Information Table 146. Zambon Business Overview Table 147. Zambon Inhalable Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Zambon Inhalable Drug Delivery Devices Product Portfolio Table 149. Zambon Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Inhalable Drug Delivery Devices Distributors List Table 153. Inhalable Drug Delivery Devices Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Inhalable Drug Delivery Devices Product Image Figure 2. Global Inhalable Drug Delivery Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalable Drug Delivery Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhalable Drug Delivery Devices Sales (2021-2032) & (k units) Figure 5. Global Inhalable Drug Delivery Devices Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Inhalable Drug Delivery Devices Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Nebulizers Image Figure 9. Pressurized Metered Dose Inhalers (PMDIs) Image Figure 10. Dry Powder Inhalers (DPIs) Image Figure 11. Others Image Figure 12. Global Inhalable Drug Delivery Devices Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Inhalable Drug Delivery Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Inhalable Drug Delivery Devices Sales Market Share by Type (2021-2032) Figure 15. Global Inhalable Drug Delivery Devices Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Inhalable Drug Delivery Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Inhalable Drug Delivery Devices Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Inhalable Drug Delivery Devices Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Inhalable Drug Delivery Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Inhalable Drug Delivery Devices Sales Market Share by Application (2021-2032) Figure 24. Global Inhalable Drug Delivery Devices Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Inhalable Drug Delivery Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Inhalable Drug Delivery Devices Revenue Market Share by Application (2021-2032) Figure 27. North America Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Inhalable Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 29. U.S. Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Inhalable Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 34. Germany Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Inhalable Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 41. China Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Inhalable Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 49. Brazil Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Inhalable Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Inhalable Drug Delivery Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Inhalable Drug Delivery Devices Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Inhalable Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 60. North America Inhalable Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Inhalable Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 62. Europe Inhalable Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Inhalable Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Inhalable Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Inhalable Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Inhalable Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Inhalable Drug Delivery Devices Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Inhalable Drug Delivery Devices Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Nebulizers
  • Pressurized Metered Dose Inhalers (PMDIs)
  • Dry Powder Inhalers (DPIs)
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Acorda Therapeutics Inc
  • Baxter International Inc
  • Bellerophon Therapeutics Inc
  • Canigma A.L LTD
  • Edixomed Ltd
  • IDTx Systems, Inc.
  • Impel NeuroPharma Inc
  • Kanabo Research Ltd
  • Mallinckrodt Plc
  • Medical Developments International Ltd
  • Medspray BV
  • NeuroproteXeon Inc
  • Next Safety, Inc.
  • Nobilis Therapeutics Inc
  • Sandoz International GmbH
  • Vero biotech
  • Zambon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Inhalable Drug Delivery Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Inhalable Drug Delivery Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Inhalable Drug Delivery Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Inhalable Drug Delivery Devices Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Inhalable Drug Delivery Devices Market Dynamics
  1. 2.1 Inhalable Drug Delivery Devices Industry Trends
  2. 2.2 Inhalable Drug Delivery Devices Industry Drivers
  3. 2.3 Inhalable Drug Delivery Devices Industry Opportunities and Challenges
  4. 2.4 Inhalable Drug Delivery Devices Industry Restraints
3 Inhalable Drug Delivery Devices Market by Manufacturers
  1. 3.1 Global Inhalable Drug Delivery Devices Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Inhalable Drug Delivery Devices Sales by Manufacturers (2021-2026)
  3. 3.3 Global Inhalable Drug Delivery Devices Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Inhalable Drug Delivery Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inhalable Drug Delivery Devices Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Inhalable Drug Delivery Devices Manufacturers, Product Type & Application
  7. 3.7 Global Inhalable Drug Delivery Devices Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inhalable Drug Delivery Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inhalable Drug Delivery Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inhalable Drug Delivery Devices Tier 1, Tier 2, and Tier 3
4 Inhalable Drug Delivery Devices Market by Type
  1. 4.1 Inhalable Drug Delivery Devices Type Introduction
  2. 4.1.1 Nebulizers
  3. 4.1.2 Pressurized Metered Dose Inhalers (PMDIs)
  4. 4.1.3 Dry Powder Inhalers (DPIs)
  5. 4.1.4 Others
  6. 4.2 Global Inhalable Drug Delivery Devices Sales by Type
  7. 4.2.1 Global Inhalable Drug Delivery Devices Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Inhalable Drug Delivery Devices Sales by Type (2021-2032)
  9. 4.2.3 Global Inhalable Drug Delivery Devices Sales Market Share by Type (2021-2032)
  10. 4.3 Global Inhalable Drug Delivery Devices Revenue by Type
  11. 4.3.1 Global Inhalable Drug Delivery Devices Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Inhalable Drug Delivery Devices Revenue by Type (2021-2032)
  13. 4.3.3 Global Inhalable Drug Delivery Devices Revenue Market Share by Type (2021-2032)
5 Inhalable Drug Delivery Devices Market by Application
  1. 5.1 Inhalable Drug Delivery Devices Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Inhalable Drug Delivery Devices Sales by Application
  6. 5.2.1 Global Inhalable Drug Delivery Devices Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Inhalable Drug Delivery Devices Sales by Application (2021-2032)
  8. 5.2.3 Global Inhalable Drug Delivery Devices Sales Market Share by Application (2021-2032)
  9. 5.3 Global Inhalable Drug Delivery Devices Revenue by Application
  10. 5.3.1 Global Inhalable Drug Delivery Devices Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Inhalable Drug Delivery Devices Revenue by Application (2021-2032)
  12. 5.3.3 Global Inhalable Drug Delivery Devices Revenue Market Share by Application (2021-2032)
6 Global Inhalable Drug Delivery Devices Sales by Region
  1. 6.1 Global Inhalable Drug Delivery Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhalable Drug Delivery Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Inhalable Drug Delivery Devices Sales by Region (2021-2026)
  4. 6.2.2 Global Inhalable Drug Delivery Devices Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Inhalable Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Inhalable Drug Delivery Devices Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Inhalable Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Inhalable Drug Delivery Devices Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Inhalable Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Inhalable Drug Delivery Devices Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Inhalable Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Inhalable Drug Delivery Devices Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Inhalable Drug Delivery Devices Revenue by Region
  1. 7.1 Global Inhalable Drug Delivery Devices Revenue by Region
  2. 7.1.1 Global Inhalable Drug Delivery Devices Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Inhalable Drug Delivery Devices Revenue by Region (2021-2026)
  4. 7.1.3 Global Inhalable Drug Delivery Devices Revenue by Region (2027-2032)
  5. 7.1.4 Global Inhalable Drug Delivery Devices Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Inhalable Drug Delivery Devices Revenue (2021-2032)
  8. 7.2.2 North America Inhalable Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Inhalable Drug Delivery Devices Revenue (2021-2032)
  11. 7.3.2 Europe Inhalable Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Inhalable Drug Delivery Devices Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Inhalable Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Inhalable Drug Delivery Devices Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Inhalable Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Acorda Therapeutics Inc
  2. 8.1.1 Acorda Therapeutics Inc Company Information
  3. 8.1.2 Acorda Therapeutics Inc Business Overview
  4. 8.1.3 Acorda Therapeutics Inc Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Acorda Therapeutics Inc Inhalable Drug Delivery Devices Product Portfolio
  6. 8.1.5 Acorda Therapeutics Inc Recent Developments
  7. 8.2 Baxter International Inc
  8. 8.2.1 Baxter International Inc Company Information
  9. 8.2.2 Baxter International Inc Business Overview
  10. 8.2.3 Baxter International Inc Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Baxter International Inc Inhalable Drug Delivery Devices Product Portfolio
  12. 8.2.5 Baxter International Inc Recent Developments
  13. 8.3 Bellerophon Therapeutics Inc
  14. 8.3.1 Bellerophon Therapeutics Inc Company Information
  15. 8.3.2 Bellerophon Therapeutics Inc Business Overview
  16. 8.3.3 Bellerophon Therapeutics Inc Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bellerophon Therapeutics Inc Inhalable Drug Delivery Devices Product Portfolio
  18. 8.3.5 Bellerophon Therapeutics Inc Recent Developments
  19. 8.4 Canigma A.L LTD
  20. 8.4.1 Canigma A.L LTD Company Information
  21. 8.4.2 Canigma A.L LTD Business Overview
  22. 8.4.3 Canigma A.L LTD Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Canigma A.L LTD Inhalable Drug Delivery Devices Product Portfolio
  24. 8.4.5 Canigma A.L LTD Recent Developments
  25. 8.5 Edixomed Ltd
  26. 8.5.1 Edixomed Ltd Company Information
  27. 8.5.2 Edixomed Ltd Business Overview
  28. 8.5.3 Edixomed Ltd Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Edixomed Ltd Inhalable Drug Delivery Devices Product Portfolio
  30. 8.5.5 Edixomed Ltd Recent Developments
  31. 8.6 IDTx Systems, Inc.
  32. 8.6.1 IDTx Systems, Inc. Company Information
  33. 8.6.2 IDTx Systems, Inc. Business Overview
  34. 8.6.3 IDTx Systems, Inc. Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 IDTx Systems, Inc. Inhalable Drug Delivery Devices Product Portfolio
  36. 8.6.5 IDTx Systems, Inc. Recent Developments
  37. 8.7 Impel NeuroPharma Inc
  38. 8.7.1 Impel NeuroPharma Inc Company Information
  39. 8.7.2 Impel NeuroPharma Inc Business Overview
  40. 8.7.3 Impel NeuroPharma Inc Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Impel NeuroPharma Inc Inhalable Drug Delivery Devices Product Portfolio
  42. 8.7.5 Impel NeuroPharma Inc Recent Developments
  43. 8.8 Kanabo Research Ltd
  44. 8.8.1 Kanabo Research Ltd Company Information
  45. 8.8.2 Kanabo Research Ltd Business Overview
  46. 8.8.3 Kanabo Research Ltd Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Kanabo Research Ltd Inhalable Drug Delivery Devices Product Portfolio
  48. 8.8.5 Kanabo Research Ltd Recent Developments
  49. 8.9 Mallinckrodt Plc
  50. 8.9.1 Mallinckrodt Plc Company Information
  51. 8.9.2 Mallinckrodt Plc Business Overview
  52. 8.9.3 Mallinckrodt Plc Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mallinckrodt Plc Inhalable Drug Delivery Devices Product Portfolio
  54. 8.9.5 Mallinckrodt Plc Recent Developments
  55. 8.10 Medical Developments International Ltd
  56. 8.10.1 Medical Developments International Ltd Company Information
  57. 8.10.2 Medical Developments International Ltd Business Overview
  58. 8.10.3 Medical Developments International Ltd Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Medical Developments International Ltd Inhalable Drug Delivery Devices Product Portfolio
  60. 8.10.5 Medical Developments International Ltd Recent Developments
  61. 8.11 Medspray BV
  62. 8.11.1 Medspray BV Company Information
  63. 8.11.2 Medspray BV Business Overview
  64. 8.11.3 Medspray BV Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Medspray BV Inhalable Drug Delivery Devices Product Portfolio
  66. 8.11.5 Medspray BV Recent Developments
  67. 8.12 NeuroproteXeon Inc
  68. 8.12.1 NeuroproteXeon Inc Company Information
  69. 8.12.2 NeuroproteXeon Inc Business Overview
  70. 8.12.3 NeuroproteXeon Inc Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 NeuroproteXeon Inc Inhalable Drug Delivery Devices Product Portfolio
  72. 8.12.5 NeuroproteXeon Inc Recent Developments
  73. 8.13 Next Safety, Inc.
  74. 8.13.1 Next Safety, Inc. Company Information
  75. 8.13.2 Next Safety, Inc. Business Overview
  76. 8.13.3 Next Safety, Inc. Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Next Safety, Inc. Inhalable Drug Delivery Devices Product Portfolio
  78. 8.13.5 Next Safety, Inc. Recent Developments
  79. 8.14 Nobilis Therapeutics Inc
  80. 8.14.1 Nobilis Therapeutics Inc Company Information
  81. 8.14.2 Nobilis Therapeutics Inc Business Overview
  82. 8.14.3 Nobilis Therapeutics Inc Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Nobilis Therapeutics Inc Inhalable Drug Delivery Devices Product Portfolio
  84. 8.14.5 Nobilis Therapeutics Inc Recent Developments
  85. 8.15 Sandoz International GmbH
  86. 8.15.1 Sandoz International GmbH Company Information
  87. 8.15.2 Sandoz International GmbH Business Overview
  88. 8.15.3 Sandoz International GmbH Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sandoz International GmbH Inhalable Drug Delivery Devices Product Portfolio
  90. 8.15.5 Sandoz International GmbH Recent Developments
  91. 8.16 Vero biotech
  92. 8.16.1 Vero biotech Company Information
  93. 8.16.2 Vero biotech Business Overview
  94. 8.16.3 Vero biotech Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Vero biotech Inhalable Drug Delivery Devices Product Portfolio
  96. 8.16.5 Vero biotech Recent Developments
  97. 8.17 Zambon
  98. 8.17.1 Zambon Company Information
  99. 8.17.2 Zambon Business Overview
  100. 8.17.3 Zambon Inhalable Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Zambon Inhalable Drug Delivery Devices Product Portfolio
  102. 8.17.5 Zambon Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhalable Drug Delivery Devices Value Chain Analysis
  2. 9.1.1 Inhalable Drug Delivery Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhalable Drug Delivery Devices Production Mode & Process
  6. 9.2 Inhalable Drug Delivery Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhalable Drug Delivery Devices Distributors
  9. 9.2.3 Inhalable Drug Delivery Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst